doi:10.1007/s00011-022-01614-x...
Springer
Neurology
2022
12/8/2022
Background and objectives miRNAs play a crucial role in regulating immune responses.
However, the effect of miR-124-3p on type 2 inflammation in allergic rhinitis (AR) is unclear.
We aimed to study the immune regulation of miR-124-3p in AR and the mechanisms involved.
Methods The direct interaction between miR-124-3p and IL-4Rα was confirmed through a dual-luciferase reporter assay.
In vitro splenic lymphocytes from mice and peripheral blood mononuclear cells (PBMCs) from healthy individuals were cultured and treated with miR-124-3p mimic/inhibitor.
Twenty-four female C57BL/C mice were divided into four groups: control, AR model, miR-124-3p agomir, and miR-124-3p antagomir groups ( n = 6 per group).
The allergic responses were evaluated based on the number of sneezing and nasal scratching, the serum HDM-specific IgE (sIgE) levels, and the degree of nasal mucosa eosinophil infiltration.
The expression of IL-4Rα, p-STAT6, and type 2 inflammatory cytokines (IL-4, IL-5 and IL-13) in lymphocytes or nasal mucosa was determined by qPCR, western blotting, flow cytometry, immunohistochemistry and immunofluorescence.
Results miR-124-3p directly targets the 3'UTR of IL-4Rα.
The miR-124-3p mimic lowered the IL-4Rα, p-STAT6, IL-4, IL-5, and IL-13 expression levels in both mouse splenic lymphocytes and human PBMCs in vitro, and the miR-124-3p inhibitor rescued these changes.
Furthermore, the miR-124-3p agomir decreased the levels of IL-4Rα and IL-4 in nasal mucosa, Th2 differentiation in spleen, and allergic response in AR mice.
Moreover, the miR-124-3p antagonist increased the IL-4Rα and IL-4 levels and further aggravated the allergic responses.
Conclusions miR-124-3p might attenuate type 2 inflammation in AR by regulating IL-4Rα signaling, and miR-124-3p may be a promising new target in AR treatment.
Liu, Qian,Shen, Yang,Xiao, Yifang,Xiang, Hong,Chu, Ling,Wang, Tiansheng,Liu, Honghui,Tan, Guolin, 2022, Increased miR-124-3p alleviates type 2 inflammatory response in allergic rhinitis via IL-4Rα, Springer